Literature DB >> 21683186

Balloon-occluded retrograde transvenous obliteration for a portosystemic shunt after pediatric living-donor liver transplantation.

Takanobu Shigeta1, Mureo Kasahara, Seisuke Sakamoto, Akinari Fukuda, Toshihiko Kakiuchi, Naoto Matsuno, Hideaki Tanaka, Osamu Miyazaki, Yoshinori Isobe, Shunuke Nosaka, Atsuko Nakazawa.   

Abstract

Portosystemic shunts may cause steal phenomenon after liver transplantation, which can lead to graft loss without proper management. Portal vein stenosis is one of the causes for the occurrence of portosystemic shunts after liver transplantation. Recently, new interventional radiologic techniques have been developed in the field of liver transplantation. Balloon-occluded retrograde transvenous obliteration (B-RTO) is a novel interventional technique for gastric varices and portosystemic shunts and also is effective for increasing portal vein flow. We herein report a pediatric case of portal vein stenosis with a large shunt successfully treated with a combination of balloon dilatation and B-RTO. If enlarged collateral vessels cause steal phenomenon, then B-RTO should be considered as an additional therapy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21683186     DOI: 10.1016/j.jpedsurg.2011.03.077

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Impact of posttransplant portosystemic shunts on liver transplantation.

Authors:  Yukihiro Sanada; Koichi Mizuta; Taizen Urahashi; Taiichi Wakiya; Yoshiyuki Ihara; Noriki Okada; Naoya Yamada; Manabu Nakata; Yoshikazu Yasuda
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

Review 2.  Portal vein complications after pediatric liver transplantation.

Authors:  Fernando Alvarez
Journal:  Curr Gastroenterol Rep       Date:  2012-06

Review 3.  Management of spontaneous portosystemic shunts at the time of liver transplantation: treatment or observation? Results of a systematic review.

Authors:  Caterina Cusumano; Stefano Gussago; Martina Guerra; Chloe Paul; François Faitot; Philippe Bachellier; Pietro Addeo
Journal:  Hepatol Int       Date:  2022-08-08       Impact factor: 9.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.